125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts
- PMID: 977646
- PMCID: PMC2109737
- DOI: 10.1083/jcb.71.1.159
125I-labeled human epidermal growth factor. Binding, internalization, and degradation in human fibroblasts
Abstract
125I-labeled human epidermal growth factor (hEGF) binds in a specific and saturable manner to human fibroblasts. At 37 degrees C, the cell-bound 125I-hEGF initially may be recovered in a native form by acid extraction; upon subsequent incubation, the cell-bound 125I-hEGF is degraded very rapidly, with the appearance in the medium of 125I-monoiodotyrosine. At 0 degrees C, cell-bound 125I-hEGF is not degraded but slowly dissociates from the cell. The data are consistent with a mechanism in which 125I-hEGF initially is bound to the cell surface and subsequently is internlized before degradation. The degradation is blocked by inhibitors of metabolic energy production (azide, cyanide, dinitrophenol), some protease inhibitors (Tos-Lys-CH2Cl, benzyl guanidobenzoate), a lysosomotropic agent (chloroquine) various local anesthetics (cocaine, lidocaine, procaine), and ammonium chloride. After the binding and degradation of 125I-hEGF the fibroblasts are no longer able to rebind fresh hormone. The binding capacity of these cells is restored by incubation in a serum-containing medium; this restoration is inhibited by cycloheximide or actinomycin D.
Similar articles
-
Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells.J Cell Biol. 1986 Mar;102(3):878-88. doi: 10.1083/jcb.102.3.878. J Cell Biol. 1986. PMID: 2869047 Free PMC article.
-
Internalization of transforming growth factor-beta and its receptor in BALB/c 3T3 fibroblasts.J Cell Physiol. 1986 Aug;128(2):216-22. doi: 10.1002/jcp.1041280212. J Cell Physiol. 1986. PMID: 2874147
-
Kinetic analysis of internalization, recycling and redistribution of atrial natriuretic factor-receptor complex in cultured vascular smooth-muscle cells. Ligand-dependent receptor down-regulation.Biochem J. 1992 Nov 15;288 ( Pt 1)(Pt 1):55-61. doi: 10.1042/bj2880055. Biochem J. 1992. PMID: 1445281 Free PMC article.
-
Chloroquine allows the secretion of internalized 125I-epidermal growth factor from fibroblasts.J Cell Physiol. 1985 Nov;125(2):215-22. doi: 10.1002/jcp.1041250207. J Cell Physiol. 1985. PMID: 3877059
-
Urinary transforming growth factors in neoplasia: separation of 125I-labeled transforming growth factor-alpha from epidermal growth factor in human urine.Cancer Res. 1986 Nov;46(11):6004-10. Cancer Res. 1986. PMID: 3019543
Cited by
-
Receptor-mediated endocytosis: insights from the lipoprotein receptor system.Proc Natl Acad Sci U S A. 1979 Jul;76(7):3330-7. doi: 10.1073/pnas.76.7.3330. Proc Natl Acad Sci U S A. 1979. PMID: 226968 Free PMC article. Review.
-
Molecular mechanism of mitogen action: processing of receptor induced by epidermal growth factor.Proc Natl Acad Sci U S A. 1978 Jun;75(6):2644-8. doi: 10.1073/pnas.75.6.2644. Proc Natl Acad Sci U S A. 1978. PMID: 307248 Free PMC article.
-
Mechanism of tumor promoter inhibition of cellular binding of epidermal growth factor.Proc Natl Acad Sci U S A. 1979 Oct;76(10):5168-72. doi: 10.1073/pnas.76.10.5168. Proc Natl Acad Sci U S A. 1979. PMID: 315558 Free PMC article.
-
Receptor-bound somatostatin and epidermal growth factor are processed differently in GH4C1 rat pituitary cells.J Cell Biol. 1986 Mar;102(3):878-88. doi: 10.1083/jcb.102.3.878. J Cell Biol. 1986. PMID: 2869047 Free PMC article.
-
Identification and characterization of cellular binding proteins (receptors) for recombinant human bone morphogenetic protein 2B, an initiator of bone differentiation cascade.Proc Natl Acad Sci U S A. 1991 Apr 15;88(8):3397-401. doi: 10.1073/pnas.88.8.3397. Proc Natl Acad Sci U S A. 1991. PMID: 1849655 Free PMC article.
References
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Other Literature Sources